Samuel D Banister Selected Research

cumyl-PINACA

2/2019	Synthesis and pharmacology of new psychoactive substance 5F-CUMYL-P7AICA, a scaffold- hopping analog of synthetic cannabinoid receptor agonists 5F-CUMYL-PICA and 5F-CUMYL-PINACA.
10/2017	Pharmacology of Cumyl-Carboxamide Synthetic Cannabinoid New Psychoactive Substances (NPS) CUMYL-BICA, CUMYL-PICA, CUMYL-5F-PICA, CUMYL-5F-PINACA, and Their Analogues.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Samuel D Banister Research Topics

Disease

7	Hypothermia 01/2022 - 08/2015
4	Epilepsy (Aura) 06/2022 - 01/2021
3	Seizures (Absence Seizure) 01/2022 - 11/2019
3	Myoclonic Epilepsies (Myoclonic Encephalopathy) 01/2022 - 11/2019
3	Pica (Geophagia) 11/2020 - 10/2017
3	Neuralgia (Stump Neuralgia) 11/2019 - 10/2016
3	Bradycardia 10/2017 - 09/2015
3	Schizophrenia (Dementia Praecox) 01/2016 - 05/2015
2	Neuroinflammatory Diseases 04/2020 - 01/2013
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 01/2018
2	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 05/2015
2	Multiple Sclerosis 11/2019 - 01/2019
2	Central Nervous System Diseases (CNS Diseases) 01/2016 - 03/2013
1	Pain (Aches) 01/2022
1	Respiratory Acidosis 01/2020
1	Obesity 11/2019
1	Psychotic Disorders (Schizoaffective Disorder) 01/2019
1	Anorexia Nervosa 01/2019
1	Tourette Syndrome (Tourette's Syndrome) 01/2019
1	Nausea 01/2019
1	Vomiting 01/2019
1	Chronic Pain 01/2019
1	Cognitive Dysfunction 01/2019
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018
1	Weight Gain 01/2017
1	Glioblastoma (Glioblastoma Multiforme) 01/2017
1	Memory Disorders (Memory Loss) 01/2017
1	Neoplasms (Cancer) 01/2017
1	Nervous System Diseases (Neurological Disorders) 10/2016
1	Glioma (Gliomas) 03/2015
1	Brain Diseases (Brain Disorder) 01/2013
1	Brain Ischemia (Cerebral Ischemia) 01/2013

Drug/Important Bio-Agent (IBA)

6	Pharmaceutical PreparationsIBA 06/2022 - 10/2016
5	CannabinoidsIBA 01/2022 - 01/2017
4	Proteins (Proteins, Gene)FDA Link 04/2020 - 01/2013
3	Anticonvulsants (Antiepileptic Drugs)IBA 01/2022 - 11/2019
3	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2022 - 11/2019
3	LigandsIBA 01/2017 - 01/2013
3	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2016 - 05/2015
2	T-Type Calcium Channels (T-Type Calcium Channel)IBA 01/2022 - 01/2022
2	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2022 - 05/2019
2	cumyl-PINACAIBA 02/2019 - 10/2017
2	N- (1- amino- 3- methyl- 1- oxobutan- 2- yl)- 1- pentyl- 1H- indazole- 3- carboxamideIBA 01/2017 - 09/2015
2	AB-FUBINACAIBA 01/2017 - 09/2015
2	N,N- diethyl- 2- (2- (4- (2- fluoroethoxy)phenyl)- 5,7- dimethylpyrazolo(1,5- a)pyrimidin- 3- yl)acetamideIBA 01/2017 - 01/2013
1	Terpenes (Terpenoids)IBA 06/2022
1	CannabidiolIBA 06/2022
1	SodiumIBA 06/2022
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2022
1	olivetolic acidIBA 01/2022
1	cannabigerolic acidIBA 01/2022
1	EstersIBA 01/2022
1	Illicit Drugs (Recreational Drugs)IBA 01/2022
1	cannabichromeneIBA 01/2021
1	OilsIBA 01/2021
1	5F-CUMYL-PICAIBA 11/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Opioid Analgesics (Opioids)IBA 01/2020
1	AcidsIBA 11/2019
1	cannabidiolic acidIBA 11/2019
1	5F-CUMYL-P7AICAIBA 02/2019
1	ZLN005IBA 01/2018
1	pyrimidineIBA 01/2017
1	acetamideIBA 01/2017
1	Ether (Diethyl Ether)IBA 01/2017
1	Dronabinol (THC)FDA LinkGeneric 01/2017
1	N,N- diethyl- 2- (2- (4- methoxyphenyl)- 5,7- dimethyl- pyrazolo(1,5- a)pyrimidin- 3- yl)- acetamideIBA 01/2017
1	Sigma-1 ReceptorIBA 10/2016
1	methyl (1- (5- fluoropentyl)- 1H- indazole- 3- carbonyl)valinateIBA 01/2016
1	1-pentyl-3-(1-naphthoyl)indoleIBA 08/2015
1	PregnenoloneIBA 03/2015
1	(R)- (11C)1- (2- chlorophenyl)- N- methyl- N- (1- methylpropyl)- 3- isoquinolinecarboxamideIBA 01/2013
1	PK 11195 (PK11195)IBA 01/2013

Therapy/Procedure

2	Induced Hyperthermia (Thermotherapy) 01/2022 - 01/2021
2	Therapeutics 05/2019 - 01/2017
2	Induced Hypothermia 10/2017 - 09/2015
1	Drug Therapy (Chemotherapy) 01/2019